RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

GlaxoSmithKline PLC

A collection of news and information related to GlaxoSmithKline PLC published by this site and its partners.

Top GlaxoSmithKline PLC Articles

Displaying items 45-55
  • Chinese dissident, in TV shaming, apologizes for spilling secrets

    Chinese dissident, in TV shaming, apologizes for spilling secrets
    One of China’s most venerable dissident journalists was paraded  on state television Thursday morning, apologizing for spilling state secrets that embarrassed the Chinese Communist Party. The public shaming of Gao Yu, a 70-year-old grandmother who...
  • FDA approves skin cancer drugs and genetic test

    FDA approves skin cancer drugs and genetic test
    The Food and Drug Administration on Wednesday announced its approval of two new drugs and a diagnostic test that can be used to treat advanced or inoperable melanoma, the most dangerous form of skin disease. Advanced melanoma has joined a wide range...
  • Animal studies riddled with bias, report finds

    Animal studies riddled with bias, report finds
    Too much good news in medicine may be bad news for science, according to a new study that suggests animal research is riddled with bias that allows too many treatments to advance to human trials. Researchers examined data from thousands of experiments...
  • Infertility due to old eggs? An anti-aging pioneer ponders solutions

    Infertility due to old eggs? An anti-aging pioneer ponders solutions
    One of the many ways in which humans' evolved characteristics clash with a fast-changing post-industrial society can be seen in the female egg. Even before a woman passes the age of 30, the quality of the oocytes she carries begins a downturn in...
  • Avandia review by FDA examines whether dangers were overdrawn

    Avandia review by FDA examines whether dangers were overdrawn
    Three years after the Food and Drug Administration was taken to task for overlooking safety problems with the diabetes drug Avandia, a panel of FDA advisors met Wednesday to open a two-day review of the research that guided the agency's actions. The...
  • FDA panel recommends continued Avandia sales, with restrictions

    FDA panel recommends continued Avandia sales, with restrictions
    An advisory panel to the Food and Drug Administration on Thursday voted to keep the diabetes drug Avandia on the market with a slate of restrictions on its use, and suggested that although evidence of the drug's safety problems may have been overblown,...
  • Bad news on red meat: Eating more is linked to diabetes risk

    Bad news on red meat: Eating more is linked to diabetes risk
    Nutritionists known for issuing warnings about the health risks of eating red meat reiterated their message this week, confirming a link between red meat consumption and Type 2 diabetes -- and showing, in a new follow-up study, that the association...
  • Former head of GlaxoSmithKline in China is accused of bribery

    The former head of GlaxoSmithKline in China was charged with corruption by local authorities after a probe that resulted in accusations that the drug maker ran a wide-ranging bribery scheme that included payoffs to doctors. Chinese police alleged that...
  • Ready to Quit Smoking?

    Ready to Quit Smoking?
    It's one instance where quitting isn't the easy way out. -------------------- FOR THE RECORD: Zyban: In Monday's Health section, an article on quitting smoking said that the smoking-cessation medication Zyban might act by blocking the brain chemicals...
  • Today's daily briefing

    Keep up-to-date with the latest health headlines. Every day, you'll find links to the newest articles on medicine, health and wellness -- the information you need to stay informed. -------------------- KFC Starts Frying With Less Harmful Oil, People...
  • Deals of the day -- mergers and acquisitions

    July 25 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Thursday: ** Dell Inc founder Michael Dell raised his $24.4 billion bid by less than 1 percent just hours before it was to be put to a vote,...